Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Nanocellulose-Based Delivery Systems and Cervical Cancer: Review of the Literature Publisher Pubmed



Sadoughi F1 ; Hallajzadeh J2 ; Asemi Z1 ; Mansournia MA3 ; Yousefi B4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
  2. 2. Department of Biochemistry and Nutrition, Research Center for Evidence-Based Health Management, Maragheh University of Medical Sciences, Maragheh, Iran
  3. 3. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  5. 5. Department of Biochemistry, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

Source: Current Pharmaceutical Design Published:2021


Abstract

It has become clear that targeted therapy is one of the best options for decreasing the unpleasant side effects of existing common methods and reducing the number of deaths occurred due to many types of cancer. Biocompatible and non-toxic delivery systems are provided by nanomedicine for aiding targeted therapy in many diseases containing cancer. Cervical cancer (CC) is not only the most common gynecological cancer but also is ranked as the fourth common cancer between both men and women. Chemotherapy, radiotherapy, surgery, and immunotherapy are the approaches, which are being used for treating CC patients. However, more efficacy of these methods can be achieved with the help of nanomedicine and novel delivery systems. Nanocellulose is one of the agents used for designing these systems in order to deliver different drugs to a diversity of cancerous cells. In this review, we aim to investigate the competency of nanocellulose for establishing novel therapeutic methods for cervical cancer. We hope that our results help develop more drug delivery systems for targeted therapy to reduce the side effects and induce the efficacy of anti-cancer drugs. © 2021 Bentham Science Publishers.
Other Related Docs
11. Lifetime Prevalence of Cervical Cancer Screening in 55 Low-And Middle-Income Countries, JAMA - Journal of the American Medical Association (2020)
16. Marketed Antiparasitic Nanotechnology-Based Products and Drawbacks, Advances in Antiparasitic Therapies and Drug Delivery (2023)
17. Anti-Tumor Activities of Probiotics in Cervical Cancer, Journal of Ovarian Research (2020)
24. Smart Internal Stimulus-Responsive Nanocarriers for Drug and Gene Delivery, Smart internal stimulus-responsive nanocarriers for drug and gene delivery (2015)